Participation in the CHANGE project
We are proud to announce our participation in the CHANGE project May 4th, 2023, Vienna, Austria The CHANGE project focuses on
By Giulia Corso|2023-07-11T09:18:04+00:00May 4th, 2023|EU funded project, Extracellular vesicles and ageing, mesenchymal stromal cells|
We are proud to announce our participation in the CHANGE project May 4th, 2023, Vienna, Austria The CHANGE project focuses on
By Giulia Corso|2023-04-05T11:15:37+00:00April 4th, 2023|Extracellular vesicles, mesenchymal stromal cells|
Recent publication showcasing our telomerized Wharton's jelly-MSCs as EV-cell factories April 4th, 2023, Vienna, AustriaOur telomerized Wharton's jelly-derived MSCs (WJ-MSC/TERT273)
By Evercyte|2021-10-08T08:13:44+00:00September 17th, 2021|Extracellular vesicles|
Engineering of CD81 on extracellular vesicles to target specific cell surface proteins. September 17, 2021, Vienna, AustriaWe have developed a platform technology
By admin|2021-09-17T15:46:31+00:00April 9th, 2021|Extracellular vesicles|
MDimune and Evercyte form partnership for developing tumor-targeting EVs April 1, 2021, Seoul, Korea and Vienna, Austria MDimune Inc. and Evercyte GmbH announced a